期刊文献+

小檗碱对阿尔茨海默病转基因鼠空间记忆力的影响 被引量:2

Effect of berberine on spatial memory in transgenic mice with Alzheimer's disease
原文传递
导出
摘要 目的探讨小檗碱对AD转基因鼠空间记忆力的影响。方法24只6月龄AD转基因鼠按随机数字表法分为模型组、小檗碱小剂量组、小檗碱中剂量组和小檗碱大剂量组,后三组小鼠分别每天灌胃给予小檗碱10mg/(kg·d)、50mg/(kg·d)和200mg/(kg·d)N10月龄。通过Morris水迷宫试验和ELISA法检测不同剂量小檗碱对AD转基因鼠空间记忆力和脑组织B淀粉样蛋白40、42(Aβ40、Aβ42)水平的影响。结果与模型组相比,各小檗碱组小鼠逃避潜伏期在测试第6天时均明显缩短.穿越平台的次数均明显增加,脑组织Aβ40、Aβ42水平均明显降低,差异均有统计学意义伊〈0.051结论小檗碱可能抑制小鼠脑组织Aβ40、Aβ42的产生从而改善AD转基因鼠的空间记忆力。 Objective To investigate the effect ofberberine on the spatial memory oftransgenic mice with Alzheimer's disease (caused by Swedish double mutation (KM670/671NL) of amyloid precursor protein [Swe-APP]). Methods Twenty-four 6-month-old APP/SWE mice were randomly divided into 4 groups: model group, low-dose berberine treatment group, medium-dose berberine treatment group and high-dose berberine treatment group (n=6). Except mice of the model group, the mice in the other 3 groups were given berberine at dosage of 10 (mg/kg .d), 50 (mg/kg.d) and 200 (mg/kg .d), respectively, by intragastric administration once daily to 10 months' old. The spatial memory was detected by Morris water maze test, and the levels of amyloid β (Aβ40 and Aβ42) in the brain tissues were measured by enzyme linked immunosorbent assay (ELISA). Results As compared those in mice of the model group, the escape latency decreased significantly, the frequency of crossing the platform obviously increased and the levels of Aβ40 and Aβ42 decreased significantly in mice of each berberine treatment group on the 64 d of detection (P〈0.05) Conclusion Berberine might improve the spatial memory of APP/SWE mice by decreasing the levels of Aβ 40/42.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第12期1234-1237,共4页 Chinese Journal of Neuromedicine
基金 国家自然科学基金青年基金(30800359)
关键词 阿尔茨海默病 小檗碱 空间记忆力 β淀粉样蛋白40/42 Alzheimer's disease Berberine Spatial memory Aβ40/42
  • 相关文献

参考文献20

  • 1Lesne S, Koh MT, Kofilinek L, et al. A specific amyioid-beta protein assembly in the brain impairs memory [J]. Nature, 2006, 440(7082): 352-357.
  • 2Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer'sdisease [J]. Science, 2006, 314 (5800): 781-784.
  • 3Ma X, Egawa T, Kimma H, et al. Berberine-induced activation of Y-adenosine monophosphate-activated protein kina_-e and glucose transport in rat skeletal muscles[J]. Metabofism, 2010, 59(11):1619-1627.
  • 4Liu X, Li G, Zhu H, et al. Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRalpha and PPARalpha transcriptional programs [J]. Endocr J, 2010, 57( 10): 881-893.
  • 5Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004, 10(12): 1344-1351.
  • 6Kong WJ, Wei J, Zuo ZY, et al. Combination of simvastatin with berberine improves the lipid-lowering efficacy [J]. Metabolism, 2008, 57(8): 1029-1037.
  • 7Kuo CL, Chi CW, Lin TY. The anti-inflammatory potential of berberine in vitro and in vivo [J]. Cancer Lett, 2004, 203 (2): 127-137.
  • 8Huang CG, Chu ZL, Wei SJ, et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells[J]. Thromb Res, 2002, 106(4-5): 223-227.
  • 9Zeng XH, Zeng XJ, Li YY. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy[J]. Am J Cardiol, 2003, 92(2): 173-176.
  • 10Peng PL, Iisich YS, Wang CJ, etal. Inhibitory effect of betberine on the invasion of human lung cancer ceils via decreased productions of urokimase-plasminogen activator and matrix metalloproteinase-2[J]. Toxicoi Appl Pharmacoi, 2006, 214(1): 8-15.

同被引文献2

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部